课题基金 / 基金详情

Aging and Dementia in Adults with Down Syndrome

Aging and Dementia in Adults with Down Syndrome
唐氏综合症成人的衰老和痴呆
批准号:
8678955
负责人:
WAYNE P. SILVERMAN
金额:
$165.25万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-02-05 至 2017-05-31
关键词:
Academic Medical CentersActivities of Daily LivingAddressAdultAdvisory CommitteesAffectAgeAge of OnsetAgingAging-Related ProcessAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAnemiaAreaAttentionAutoimmunityBasic ScienceBiologicalBiological MarkersBiometryBlood CellsBlood specimenBrainCandidate Disease GeneCharacteristicsChromosomesChromosomes, Human, Pair 21ClassificationClinicalCognitionCognitiveCollaborationsCollectionConsensusDNA MethylationDataData CollectionData SetDementiaDevelopmentDevelopmental DisabilitiesDiagnosticDisciplineDiseaseDisease ProgressionDown SyndromeEarly DiagnosisElderlyEpigenetic ProcessFundingGeneral PopulationGeneticGenetic MarkersGenotypeGoalsHandHealthHealth StatusImpaired cognitionIndividualIndividual DifferencesInfectionInstitutesInsulin ResistanceIntellectual functioning disabilityLaboratoriesLeadershipLeukocytesLife ExpectancyLongevityMeasuresMetabolic syndromeMethodsMonitorNatureNew YorkOlder PopulationParticipantPathogenesisPatternPhenotypePopulationPopulations at RiskProceduresProcessProductivityProgress ReportsPropertyPsychometricsRecurrenceReportingResearchResearch PersonnelResearch Project GrantsRiskRisk FactorsRoleSample SizeSamplingSensitivity and SpecificitySingle Nucleotide PolymorphismStagingSymptomsTarget PopulationsTissue BankingTissue BanksUniversitiesValidationVariantWorkage effectbasecognitive changeeffective interventionexperiencefunctional statusgenetic epidemiologygenetic risk factorinsightinterestmedical schoolsmild cognitive impairmentmultidisciplinaryneuropathologynormal agingprogramstool

项目摘要

项目成果

WAYNE P. SILVERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The program of research focusing on adults with Down syndrome (DS), ongoing since 1987, will be continued, now consisting of four projects supported by three cores. While all of the projects have clear origins in the program's current activities, several new initiatives are included. The investigators will: (a) determine if individual differences in risk for Alzheimer's disease (AD) within the elderly population with DS is associated with insulin resistance and other features of metabolic syndrome; (b) develop empirically validated methods for identifying the presence of mild cognitive impairment (MCI) in adults with DS, differentiating this condition from cognitive changes associated with developmentally appropriate aging, per se; (c) determine the role of altered patterns of DNA methylation in DS pathogenesis and variation in phenotypic expression within this population, including selected aging-related processes; and (d) use independent datasets to evaluate the relations between age at onset of AD (as well as related phenotypic characteristics) and single nucleotide polymorphisms (SNPs) of approximately 60 candidate genes located on chromosome 21 as well as other chromosomes. As in the past, goals will be achieved through extensive collaborations among investigators representing multiple disciplines. Common assessment procedures, repeated at intervals of approximately 18 months, will be employed to characterize in detail the health, cognitive, and functional status of each of the 300 adults with DS actively participating in the program. Findings and biological samples from previous studies will also be available for the genetic and epigenetic studies now being proposed, bringing the total projected sample size to 788 adults with DS. Cognitive and functional changes will be related to selected biomarkers as well as genetic and epigenetic findings, providing a far richer description of this population than could occur in the context of any single research project. Findings should provide clear insights into: (a) mechanisms underlying important features of the DS phenotype, (b) individual differences in those features, (c) factors modifying risk for dementia, and (d) assessment methods that can inform diagnostic decisions relatively early in disease progression. Further, some findings may have direct implications for promoting more successful aging for adults with DS.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/1471-2350-7-24
发表时间: 2006-03-15
期刊: BMC MEDICAL GENETICS
影响因子: --
作者: [Li, CM, Guo, MR, Salas, M, Schupf, N, Silverman, W, Zigman, WB, Husain, S, Warburton, D, Thaker, H, Tycko, B]
通讯作者: Tycko, B
Faithful tissue-specific expression of the human chromosome 21-linked COL6A1 gene in BAC-transgenic mice.
人类 21 号染色体连接的 COL6A1 基因在 BAC 转基因小鼠中忠实地组织特异性表达。
DOI: 10.1007/s00335-006-0082-y
发表时间: 2007
期刊: Mammalian genome : official journal of the International Mammalian Genome Society
影响因子: --
作者: [Xing,Luzhou, Salas,Martha, Lin,Chyuan-Sheng, Zigman,Warren, Silverman,Wayne, Subramaniyam,Shivakumar, Murty,VundavalliV, Tycko,Benjamin]
通讯作者: Tycko,Benjamin
DOI: 10.1007/s00335-012-9436-9
发表时间: 2013-02
期刊: MAMMALIAN GENOME
影响因子: 2.5
作者: [Xing, Luzhou, Salas, Martha, Zhang, Hong, Gittler, Julia, Ludwig, Thomas, Lin, Chyuan-Sheng, Murty, Vundavalli V., Silverman, Wayne, Arancio, Ottavio, Tycko, Benjamin]
通讯作者: Tycko, Benjamin
DOI: 10.1186/s13059-015-0827-6
发表时间: 2015-11-25
期刊: Genome biology
影响因子: 12.3
作者: [Mendioroz M, Do C, Jiang X, Liu C, Darbary HK, Lang CF, Lin J, Thomas A, Abu-Amero S, Stanier P, Temkin A, Yale A, Liu MM, Li Y, Salas M, Kerkel K, Capone G, Silverman W, Yu YE, Moore G, Wegiel J, Tycko B]
通讯作者: Tycko B
15
    Administrative Core
    Intellectual and Developmental Disabilities Research Centers 2013
    Intellectual and Developmental Disabilities Research Centers 2013
    Administrative Core
    海外基金